| Application no. and date | 17801363.7 (espacenet) (Federated) (European Patent Register), 20171101 | | Patent/reg. no. and date | DK/EP 3534936, 20201021 | | Publication date | 20190911 | | Priority no. and date | US 201662415717 P, 20161101, EP 17150037, 20170102, EP 17169019, 20170502, EP 17177289, 20170622, EP 17198041, 20171024 | | EP pub. no. and date |
EP 3534936 20190911 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | | Applicant ref. no. | P74695DK01 | | Inventor | CHAPLIN, Jay, Novo Allé, 2880 Bagsværd, DK,
WIJARANAKULA, Michael, Novo Allé, 2880 Bagsværd, DK | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 3/10 (2006.01) | | Title | TOLEROGEN DNA-VACCINE | | Int. application no. | EP2017077949 | | Int. publication no. | WO2018083111 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
